July 23, 2009 (Paris, France) — Administering unfractionated heparin (UFH) to patients already receiving enoxaparin--a common practice in the cath lab known as stack-on--results in overanticoagulation ...
The results of the oral direct THRombin Inhibitor ximelagatran for Venous thromboEmbolism Treatment (THRIVE Treatment) phase 3 study show that ximelagatran, the first of a new class of oral direct ...
Enoxaparin injectable solution is available as both a generic and brand-name drug. Brand name: Lovenox. Enoxaparin is injected subcutaneously (under your skin). Your healthcare provider will show you ...
(San Diego, Calif., December 7, 2003) – The use of ximelagatran in patients with acute venous thromboembolism is as safe and effective as the current standard treatment of enoxaparin, according to a ...
17th International Congress on Thrombosis, Bologna, 26 October 2002: Important results from the EXPRESS clinical trial for the oral direct thrombin inhibitor (Oral DTI), EXANTA™ (oral ximelagatran and ...
Hyperhomocysteinemia in cancer patients with thrombosis is not associated with methylene tetrahydrofolate reductase (MTHFR) gene mutations is down regulated by low molecular weight heparin (LMWHs) ...
The combined use of anticoagulants, antiplatelet agents, and invasive coronary procedures reduces ischemic coronary events but also increases bleeding in patients with acute coronary syndromes. We ...
Preliminary studies have suggested that fondaparinux could be just as effective as enoxaparin in preventing ischemic events, and safer than unfractionated heparin in terms of bleeding, in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results